Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression

Por de Wit, Meike, Carvalho, Beatriz, Delis-van Diemen, Pien M., van Alphen, Carolien, Beliën, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Publicado no PLoS One (2017)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

Por Greijer, Astrid E., Delis-van Diemen, Pien M., Fijneman, Remond J. A., Giles, Rachel H., Voest, Emile E., van Hinsbergh, Victor W. M., Meijer, Gerrit A.
Publicado em 2008

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

Por Sillars-Hardebol, Anke H., Carvalho, Beatriz, de Wit, Meike, Postma, Cindy, Delis-van Diemen, Pien M., Mongera, Sandra, Ylstra, Bauke, van de Wiel, Mark A., Meijer, Gerrit A., Fijneman, Remond J. A.
Publicado em 2010

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer

Por de Wit, Meike, Belt, Eric J. Th., Delis-van Diemen, Pien M., Carvalho, Beatriz, Coupé, Veerle M. H., Stockmann, Hein B. A. C., Bril, Herman, Beliën, Jeroen A. M., Fijneman, Remond J. A., Meijer, Gerrit A.
Publicado em 2012

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

Por van den Broek, Evert, den Uil, Sjoerd H., Coupé, Veerle M.H., Delis-van Diemen, Pien M., Bolijn, Anne S., Bril, Herman, Stockmann, Hein B.A.C., van Grieken, Nicole C.T., Meijer, Gerrit A., Fijneman, Remond J.A.
Publicado no Oncotarget (2018)

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify

Por Komor, Malgorzata A., Pham, Thang V., Hiemstra, Annemieke C., Piersma, Sander R., Bolijn, Anne S., Schelfhorst, Tim, Delis-van Diemen, Pien M., Tijssen, Marianne, Sebra, Robert P., Ashby, Meredith, Meijer, Gerrit A., Jimenez, Connie R., Fijneman, Remond J. A.
Publicado no Mol Cell Proteomics (2017)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients

Por Vleugels, Jasper L.A., van Neerven, Sanne M., van Leerdam, Monique E., Wanders, Linda K., de Wit, Meike, Carvalho, Beatriz, Delis-van Diemen, Pien M., Kallenberg, Frank G.J., Vermeulen, Louis, Beliën, Jeroen A., East, James E., Meijer, Gerrit A., Dekker, Evelien
Publicado no Endosc Int Open (2019)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

Por den Uil, Sjoerd H., van den Broek, Evert, Coupé, Veerle M. H., Vellinga, Thomas T., Delis-van Diemen, Pien M., Bril, Herman, Belt, Eric J. Th., Kranenburg, Onno, Stockmann, Hein B. A. C., Belien, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Publicado no BMC Gastroenterol (2019)

Consensus molecular subtype classification of colorectal adenomas

Por Komor, Malgorzata A, Bosch, Linda JW, Bounova, Gergana, Bolijn, Anne S, Delis‐van Diemen, Pien M, Rausch, Christian, Hoogstrate, Youri, Stubbs, Andrew P, de Jong, Mark, Jenster, Guido, van Grieken, Nicole CT, Carvalho, Beatriz, Wessels, Lodewyk FA, Jimenez, Connie R, Fijneman, Remond JA, Meijer, Gerrit A
Publicado no J Pathol (2018)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9

Por Goos, Jeroen A.C.M., Coupé, Veerle M.H., van de Wiel, Mark A., Diosdado, Begoña, Delis-Van Diemen, Pien M., Hiemstra, Annemieke C., de Cuba, Erienne M.V., Beliën, Jeroen A.M., Menke - van der Houven van Oordt, C. Willemien, Geldof, Albert A., Meijer, Gerrit A., Hoekstra, Otto S., Fijneman, Remond J.A.
Publicado no Oncotarget (2015)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

Por Lenos, Kristiaan, Goos, Jeroen A.C.M., Vuist, Ilona M., den Uil, Sjoerd H., Delis-van Diemen, Pien M., Belt, Eric J.Th., Stockmann, Hein B.A.C., Bril, Herman, de Wit, Meike, Carvalho, Beatriz, Giblett, Susan, Pritchard, Catrin A., Meijer, Gerrit A., van Kooyk, Yvette, Fijneman, Remond J.A., van Vliet, Sandra J.
Publicado no Oncotarget (2015)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

Por den Uil, Sjoerd H, Coupé, Veerle M H, Linnekamp, Janneke F, van den Broek, Evert, Goos, Jeroen A C M, Delis-van Diemen, Pien M, Belt, Eric J Th, van Grieken, Nicole C T, Scott, Patricia M, Vermeulen, Louis, Medema, Jan Paul, Bril, Herman, Stockmann, Hein B A C, Cormier, Robert T, Meijer, Gerrit A, Fijneman, Remond J A
Publicado no Br J Cancer (2016)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

Por Komor, Malgorzata A., de Wit, Meike, van den Berg, Jose, Martens de Kemp, Sanne R., Delis‐van Diemen, Pien M., Bolijn, Anne S., Tijssen, Marianne, Schelfhorst, Tim, Piersma, Sander R., Chiasserini, Davide, Sanders, Joyce, Rausch, Christian, Hoogstrate, Youri, Stubbs, Andrew P., de Jong, Mark, Jenster, Guido, Carvalho, Beatriz, Meijer, Gerrit A., Jimenez, Connie R., Fijneman, Remond J.A.
Publicado no Int J Cancer (2019)